TY - JOUR AU - Amicone, Laura AU - Marchetti, Alessandra PY - 2018 TI - Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma JF - Translational Gastroenterology and Hepatology; May 2018 Y2 - 2018 KW - N2 - Hepatocellular carcinoma (HCC), is one of the most frequent human cancer and is characterized by a high mortality rate. The aggressiveness appears strictly related to the liver pathological background on which cancer develops. Inflammation and the consequent fibro/cirrhosis, derived from chronic injuries of several origins (viral, toxic and metabolic) and observable in almost all oncological patients, represents the most powerful risk factor for HCC and, at the same time, an important obstacle to the efficacy of systemic therapy. Multiple microenvironmental cues, indeed, play a pivotal role in the pathogenesis, evolution and recurrence of HCC as well as in the resistance to standard therapies observed in most of patients. The identification of altered pathways in cancer cells and of microenvironmental changes, strictly connected in pathogenic feedback loop, may permit to plan new therapeutic approaches targeting tumor cells and their permissive microenvironment, simultaneously. UR - http://tgh.amegroups.com/article/view/4249